HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

Pietrantonio, F; Manca, P; Bellomo, SE; Corso, S; Raimondi, A; Berrino, E; Morano, F; Migliore, C; Niger, M; Castagnoli, L; Pupa, SM; Marchio, C; Di Bartolomeo, M; Restuccia, E; Lambertini, C; Tabernero, J; Giordano, S

Pietrantonio, F (通讯作者)，Fdn IRCCS Ist Nazl Tumori, Via G Venezian 1, I-20133 Milan, Italy.

CLINICAL CANCER RESEARCH, 2023; 29 (3):

Abstract

Purpose: In JACOB trial, pertuzumab added to trastuzumab-chemotherapy did not significantly improve survival of patients with HER2-positive metastatic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索